C. Wang et al. / Dyes and Pigments 97 (2013) 405e411
407
83.2%). FT-IR (KBr, cmꢀ1): 944 (trans-vinylene). 1H NMR (CDCl3,
400 MHz, /ppm): 8.12e8.14 (d, 4H), 7.96 (s, 4H), 7.74 (s, 2H), 7.39e
ether/dichloromethane ¼ 1:1) to give 0.75 g 5 as a light yellow solid
d
(yield: 85%). FT-IR (KBr, cmꢀ1): 966 (trans-vinylene). 1H NMR
7.41 (d, 4H), 7.17 (s, 2H), 3.89e3.90 (d, 2H), 2.80e2.94 (m, 8H),
2.04e1.99 (m, 8H), 1.80e1.87 (m, 8H), 1.48e1.56 (m, 28H), 1.19e1.22
(t, 4H), 1.00e1.05 (m, 18H). MALDI-TOF MS (C70H85BrN4OS6) m/z:
calcd for 1270.744; found 1270.443.
(CDCl3, 400 MHz, d/ppm): 7.52 (s, 2H), 7.25e7.29 (d, 4H), 7.06e7.08
(d, 8H), 6.95e7.01 (m, 12H), 6.77e6.82 (m, 6H), 6.61e6.64 (d, 2H),
3.73e3.76 (t, 2H), 2.32 (s, 12H), 1.80e1.84 (m, 2H), 1.54 (m, 2H),
1.25e1.36 (m, 8H), 0.83e0.87 (t, 3H). 13C NMR (CDCl3, 100 MHz,
d/
ppm): 152.25, 146.95, 143.98, 132.59, 131.80, 130.77, 129.31, 128.90,
126.27, 126.17, 126.12, 124.02, 123.93, 123.82, 123.61, 121.12, 116.50,
73.81, 30.86, 29.16, 28.46, 25.17, 21.66, 19.80, 13.07. MALDI-TOF MS
(C62H63BrN2O) m/z: calcd for 930.412; found 930.548.
2.2.4. Synthesis of 5-(4-(2-ethylhexyloxy)-3,5-bis((E)-2-(3-hexyl-5-
(7-(4-hexylthiophen-2-yl)benzo[c][1,2,5]thiadiazol-4-yl)thiophen-
2-yl)vinyl)phenyl)-3-hexylthiophene-2-carbaldehyde(4)
Compound
3 (0.75 g, 0.59 mmol), (5-(1,3-dioxolan-2-yl)-4-
hexylthiophen-2 -yl)tributylstannane (0.44 g, 1.4 mmol) and
Pd(PPh3)4 (0.1 g, 0.08 mmol) were dissolved in DMF (30 mL) and
the solution was stirred at 100 ꢁC for 30 h under nitrogen atmo-
sphere. After cooling to room temperature, the resulting solution
was treated with dilute aqueous HCl (10 mL) solution. This solution
was stirred for 30 min and then extracted with dichloromethane.
The organic phase was dried over anhydrous MgSO4, and the sol-
vent was removed by rotary evaporation. The crude product was
purified using silica gel column chromatography (eluent:petroleum
ether/dichloromethane ¼ 1:1) to give 0.47 g 4 as a red solid (yield:
57.5%). FT-IR (KBr, cmꢀ1): 1660 (nC]O), 952 (trans-vinylene). 1H
2.2.7. Synthesis of 5-(3,5-bis((1E,3E)-4-(4-(dip-tolylamino)phenyl)
buta-1,3-dienyl)-4-(octyloxy)phenyl)-3-hexylthiophene-2-
carbaldehyde (6)
Compound 6 was synthesized according to compound 4, instead
using
5
(0.88 g, 1 mmol) and (5-(1,3-dioxolan-2-yl)-4-
hexylthiophen-2 -yl)tributylstannane (0.5 g, 1.12 mmol). The
crude product was purified using silica gel column chromatography
(eluent:petroleum ether/ dichloromethane ¼ 3:1) to give 0.62 g 6
as a yellow solid (yield: 68%). FT-IR (KBr, cmꢀ1): 1637 (nC]O), 983
(trans-vinylene). 1H NMR (CDCl3, 400 MHz,
d/ppm): 10.02 (s, 1H),
7.70 (s, 2H), 7.38e7.40 (d, 4H), 7.29e7.30 (m, 2H), 7.24 (s, 1H), 7.06e
7.08 (m, 2H), 6.69e7.03 (m, 24H), 3.79e3.83 (t, 2H), 2.96e2.98 (t,
2H), 2.32 (s, 12H), 1.82e1.83 (m, 2H), 1.70e1.76 (m, 2H), 1.56 (m,
2H), 1.25e1.33 (m, 14H), 0.83e0.90 (m, 6H). MALDI-TOF MS
(C73H78N2O2S) m/z: calcd for 1046.578; found 1046.747.
NMR (CDCl3, 400 MHz, d/ppm): 10.06 (s, 1H), 8.00e8.04 (d, 4H),
7.85 (s, 4H), 7.76 (s, 3H), 7.36e7.38 (d, 4H), 7.06 (s, 2H), 3.83 (s, 2H),
3.02 (s, 2H), 2.71e2.83 (m, 8H), 1.92 (s, 1H), 1.73e1.75 (m, 10H),
1.25e1.43 (m, 36H),1.06e1.08 (m, 4H), 0.91 (s, 20H). MALDI-TOF MS
(C81H100N4O2S7) m/z: calcd for 1384.589; found 1384.636.
2.2.8. Synthesis of (E)-3-(5-(3,5-bis((1E,3E)-4-(4-(dip-tolylamino)
phenyl)buta-1,3-dienyl)-4-(octyloxy)phenyl)-3-hexylthiophen-2-
yl)-2-cyanoacrylicacid (FD1)
2.2.5. Synthesis of (E)-2-cyano-3-(5-(4-(2-ethylhexyloxy)-3,5-
bis((E)-2-(3-hexyl-5-(7-(4-hexylthiophen-2-yl)benzo[c][1,2,5]
thiadiazol-4-yl)thiophen-2-yl)vinyl)phenyl)-3-hexylthiophen-2-yl)
acrylic acid (WD1)
The synthetic procedure for FD1 was similar to that for WD1,
except that compound 6 (0.60 g, 0.66 mmol) was used instead of
compound 4. The crude product was purified using silica gel col-
umn chromatography (eluent:CH2Cl2/CH3OH ¼ 10:1) to give 0.40 g
FD1 as a brown solid (yield: 84%). FT-IR (KBr, cmꢀ1): 2362 (nC^N),
Compound
4 (0.42 g, 0.3 mmol), cyanoacetic acid (0.26 g,
3.0 mmol), and piperidine (0.5 mL) were dissolved in CHCl3 (20 mL)
and CH3CN (10 mL), and the solution was refluxed at 80 ꢁC for 12 h
under nitrogen atmosphere. Then the solution was poured into
1601 (nC]O). 1H NMR (CDCl3, 400 MHz,
d/ppm): 8.48 (s, 1H), 7.72 (s,
a
diluted aqueous HCl (10 mL) solution and extracted with
2H), 7.29e7.30 (m, 5H), 6.70e7.07 (m, 28H), 3.78 (t, 2H), 2.87 (t, 2H),
2.32 (s, 12H), 1.84 (m, 2H), 1.56e1.69 (m, 4H), 1.26e1.36 (m, 14H),
dichloromethane. The organic phase was dried over anhydrous
MgSO4, and the solvent was removed by rotary evaporation. The
crude product was purified using silica gel column chromatography
(eluent:CH2Cl2/CH3OH ¼ 10:1) to give 0.24 g WD1 as a red solid
(yield: 54.5%). FT-IR (KBr, cmꢀ1): 2202 (nC^N), 1606 (nC]O). 1H NMR
0.86e0.99 (m, 6H). 13C NMR (CDCl3, 100 MHz,
d/ppm): 167.34,
156.28, 154.63, 153.26, 146.90, 144.16, 143.98, 132.61, 131.78, 131.40,
130.73,129.89,129.39,128.90,128.60,127.83,127.50,126.28,124.86,
124.11, 121.62, 121.12, 115.12, 93.74, 73.76, 32.95, 30.89, 29.23, 28.68,
28.10, 26.71, 25.53, 24.05, 23.69, 21.68, 19.81, 18.14, 13.09, 13.06.
Anal. Calcd for C76H79N3O3S: C, 81.09; H, 7.14; N, 3.77; S, 2.88.
Found: C, 81.07; H, 7.21; N, 3.75; S, 2.89. MALDI-TOF MS
(C76H79N3O3S) m/z: calcd for 1113.584; found 1113.725.
(CDCl3, 400 MHz, d/ppm): 8.40 (s, 1H), 7.98 (s, 2H), 7.95 (s, 2H), 7.91
(s, 4H), 7.69 (s, 2H), 7.39e7.35 (d, 2H), 7.29 (s, 2H), 7.25 (s, 2H), 7.01
(s, 1H), 3.79e3.78 (d, 2H), 2.83e2.76 (m, 6H), 2.67e2.64 (t, 4H),
1.90e1.87 (m, 1H), 1.70e1.65 (m, 10H), 1.38e1.21 (m, 32H), 1.05e
1.02 (t, 6H), 0.87e0.86 (m, 21H). 13C NMR (CDCl3, 100 MHz,
d/
ppm): 169.09, 157.53, 156.23, 154.33, 152.46, 152.37, 145.28, 144.22,
142.85,138.98,138.00,137.08,132.23,130.86,130.84,130.50,129.90,
128.85, 128.56, 125.75, 125.70, 125.27, 125.11, 125.03, 122.82, 122.21,
121.67, 121.33, 115.84, 94.77, 78.07, 68.23, 65.56, 41.13, 33.81, 31.93,
31.82, 31.77, 31.66, 30.95, 30.85, 30.67, 30.41, 30.16, 29.70, 29.53,
29.30, 29.28, 29.16, 28.97, 28.80, 23.42, 22.68, 22.67, 19.21, 14.32,
14.14, 14.10, 11.81. Anal. Calcd for C84H101N5O3S7: C, 69.43; H, 7.01;
N, 4.82; S, 15.45. Found: C, 68.79; H, 8.08; N, 4.43; S, 15.08. MALDI-
TOF MS (C84H101N5O3S7) m/z: calcd for 1451.595; found 1451.876.
2.3. Instruments and characterizations
1H NMR and 13C NMR spectra were measured with a Bruker
Avance 400 instrument. Elemental analysis was obtained on
PerkineElmer 2400 element analyzer. UVevisible spectra of the
dyes were measured on a PerkineElmer Lamada 25 spectrometer.
The PL spectra were obtained using PerkineElmer LS-50 lumines-
cence spectrometer. FT-IR spectra were obtained on a Perkine
Elmer Spectra One spectrometer. MALDI-TOF mass spectrometric
measurements were performed on Bruker Autoflex Ⅲ. Electro-
chemical redox potentials were obtained by cyclic voltammetry
(CV) and differential pulse voltammetry (DPV) using a three-
electrode configuration and an electrochemistry workstation
(ZAHNER ZENNIUM). The working electrode was a glassy carbon
electrode; the counter electrode was a Pt electrode, and saturated
calomel electrode (SCE) was used as reference electrode. Tetrabu-
tylammonium perchlorate (TBAP) 0.1 M was used as supporting
electrolyte in dry DMF. Ferrocene was added to each sample
2.2.6. Synthesis of N-(4-((1E,3E)-4-(5-bromo-3-((1E,3E)-4-(4-(di-
p-tolylamino)phenyl)buta-1,3-dienyl)-2-(octyloxy)phenyl)buta-1,3-
dienyl)phenyl)-4-methyl-N-p-tolylbenzenamine(5)
Compound 5 was synthesized according to compound 3, instead
using 5-bromo-1,3-bis(diethyl-phsophonate- methyl)-2-(octyloxy)
benzene (0.585 g, 1 mmol), compound 2 (0.645 g, 2 mmol) and
potassium tertbutoxide (0.46 g, 4 mmol). The crude product was
purified using silica gel column chromatography (eluent:petroleum